DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 38 · September 2005 DOI: 10.1055/s-002-4370

Review

Original Paper

206
Lambert, M.; Conus, P.; Schimmelmann, B. G.; Eide, P.; Ward, J.; Yuen, H.; Schacht, M.; Edwards, J.; Naber, D.; McGorry, P. D.: Comparison of Olanzapine and Risperidone in 367 First-Episode Patients with Non-Affective or Affective Psychosis: Results of an Open Retrospective Medical Record Study
214
Szulc, A.; Galinska, B.; Tarasow, E.; Dzienis, W.; Kubas, B.; Konarzewska, B.; Walecki, J.; Alathiaki, A. S.; Czernikiewicz, A.: The Effect of Risperidone on Metabolite Measures in the Frontal Lobe, Temporal Lobe, and Thalamus in Schizophrenic Patients. A Proton Magnetic Resonance Spectroscopy (1H MRS) Study

Letter

220
Khaldi, S.; Gourevitch, R.; Matmar, M.; Llory, A.; Olié, J.-P.; Chauvelot-Moachon, L.: Necrotizing Enterocolitis after Antipsychotic Treatment Involving Clozapine and Review of Severe Digestive Complications
222
Croissant, B.; Grosshans, M.; Klein, O.; Diehl, A.; Mann, K.: Scheme-Based Benzodiazepine Detoxification with Oxcarbazepine
223
Barnhill, J.; Susce, M. T.; Diaz, F. J.; de Leon, J.: Risperidone Half-Life in a Patient Taking Paroxetine